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In recent years a major thrust in immunology has been to clarify the morphologi- 
cal,  surface,  and  functional properties of  the  complex populations comprising  the 
lymphoid cell series. At the  core of  the  problem  is  the  mechanism  of  lymphocyte 
"activation," the process by which specific antigens or nonspecific agents stimulate 
resting lymphocytes to transform morphologically (1-5)  and to exhibit a  variety  of 
measurable immunological functions (6,  7). Some bone marrow-derived lymphocytes 
(B  lymphocytes)  L may  ultimately differentiate into  cells of  the  plasmacyte  series 
that  produce  immunoglobulin  antibodies  (8-10).  Lymphocytes  that  are  thymus 
derived or  thymus  dependent  (T  lymphocytes)  are  involved  in  cell-mediated im- 
mune  reactions,  such  as graft and  tumor  rejection and  resistance to  certain intra- 
cellular infections (7,  11, 12). Although T  lymphocytes may produce a number of fac- 
tors that affect cells in their environment  (13),  they do not produce antibody (10) 
and  it has  been  difficult to  identify and  enumerate  sensitized T  lymphocytes in  a 
given population. 
In contrast to many other body cells, resting lymphocytes are generally unable to 
support replication of a  variety of  RNA  and  DNA viruses  (see references  13-15). 
When lymphocytes are activated, either by plant mitogens or by specific antigens, 
they rapidly acquire the ability to replicate viruses. By using an infectious center or 
virus plaque assay (VPA), in which lymphocytes are stimulated by specific antigens, 
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infected with a  virus, and plated in agar above an indicator monolayer for the virus, 
it has been possible  to estimate  the number  of antigen-sensitive cells in cell popula- 
tions  from  delayed  hypersensitive  individuals.  In  exquisitely  sensitive  donors,  the 
maximal number of virus plaque-forming cells is of the order of 0.5-2%  (16). 
The purpose of this study is to explore at the ultrastructural  level the nature 
of  the  cells  engaged  in  the  production  of vesicular  stomatitis  virus  (VSV)  in 
different lymphoid cell populations,  particularly after stimulation  with several 
different  agents.  Specifically,  we  have  examined  (a)  lymph  node  cells  from 
guinea  pigs  with  delayed  hypersensitivity  activated  by  specific  antigen,  (b) 
murine  spleen  cells activated  by selective B  cell and  T  cell mitogens,  and  (c) 
cells  of  human  and  murine  continuous  lymphoblastoid  or  lymphoma  lines. 
Materials and Methods 
Preparation of Sensitized Guinea Pig Lymph Node Cdls.--Lymph node cells in suspension 
were prepared from guinea pigs sensitized with complete Freund's adjuvant  2-4 wk previ- 
ously as described elsewhere (13). The cells were cultured for 3 or 4 days at 20  X  l0  s viable 
cells/1.5 ml in Leighton tubes in Eagle's minimal essential medium  (MEM)  supplemented 
with penicillin (100 U/ml), streptomycin  (100/ag/ml),  glutamine (2 mM),  and  5% normal 
guinea pig serum.  For  specific  activation  25  #g/ml  tuberculin  purified  protein  derivative 
(PPD)  (Ministry of Fisheries, Food & Agriculture, Weybridge, Surrey, England) was added 
at zero time for a period of 4 days. 
Preparation of Mouse Spleen Cdls.--Spleens  were  removed aseptically from  C57B1/10 
mice, rinsed in cold Hanks' balanced salt solution, and sliced into three pieces in MEM sup- 
plemented with 6% fetal calf serum, penicillin, streptomycin, and 2 mM glutamine in concen- 
trations  as listed above. The cells were gently dispersed from the tissue fragments with a 
loosely fitting Potter homogenizer, the capsule was allowed to settle, and the cell suspension 
was washed twice. Approximately"  2 X  l0  s cells were obtained from a single spleen.  The cells 
were cultured in Leighton tubes at a  density of 15  X  106 cells in 1.5 ml of medium RPMI 
1640 supplemented with  10% fetal calf serum,  penicillin, streptomycin, glutamine, and  30 
#g/ml of Mycostatin. The cultures were stimulated either with 2.5 #g/ml of concanavalin 
A  (Con A) (Calbiochem, San Diego, Calif.), purified on Sephadex (17), or 20 #g/ml of Esch- 
erichia coli lipopolysaecharide  (LPS-B)  (Dlfco Laboratories,  Detroit,  Mich.).  Control  cul- 
tures were prepared without mitogens. 
Maintenance of Continuous Cell Lines.--Human  lymphoblastoid cell lines (Wil-2, 8866, and 
Rail) were maintained in stationary cultures in Dulbecco's modified Eagle's medium supple- 
mented with 10% fetal calf serum (DME). Twice a week cells were counted and diluted with 
fresh medium to 0.4  X  106 cells/ml. Cell densities ranged from 0.4  X  106 to 2  X  106/ml. 
Mouse leukemic cell lines (L1210, L5178Y,  and C57B1/6 leukemia) at 0.5  f  106 cells/ml were 
grown in Fisher's medium containing 2.5% horse serum and 0.2% trypticase soy broth. The 
EL-4 mouse leukemic cell line grew best at 0.5  X  106-1  X  106 cells/ml in DME. Guinea pig 
leukemia L2C was passed  in strain  II guinea pigs and maintained in short-term culture in 
medium RPMI 1640 with 20% fetal calf serum. All media contained 100 U/ml penicillin, 100 
/zg/ml streptomycin, and 2 mM glutamine. 
VS V and Infection of Cells.--The stock of VSV used throughout these experiments was pre- 
pared in secondary chick embryo fibroblasts (18) and its titer on mouse L cells was 109 plaque- 
forming units  (PFU)/ml. Guinea pig anti-VSV serum was prepared as previously described 
(18). Cells (2 X  106) were routinely infected at a multiplicity of infection (MOI) of 10 for 2 or 
24 h at 37°C. At the end of this period cells were washed once with MEM and treated for 1 h 1044  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
at 4°C with 0.02 ml of anti-VSV serum per sample, an amount of antiserum sufficient to neutral- 
ize completely all the input virus. Infected cells were then washed three times with MEM and 
used either for the VPA or electron microscopy (EM). 
VPA.~irus-producing cells were  assayed as previously  described  (18).  Briefly,  0.2  ml 
samples of infected cells at 10-fold dilutions (102-10 .5 cells) were plated in duplicate on mono- 
layers of L  cells in 60 mm Falcon tissue culture dishes (Falcon Plastics, Oxnard, Calif.) and 
overlaid with warm 1% agar in MEM (Ionagar no. 2, Oxnid, Colab Laboratories, Inc., Chicago 
Heights, Ill.). The plates were incubated for 2 days at 37°C in 5% CO2 in air, and plaques were 
counted after staining with neutlal red (0.1 mg/ml in phosphate-buffered saline pH 7.2).  The 
number of cells was determined at the time of plating by counting in a Coulter particle counter 
(Coulter Electronics, Inc., Hialeah, Fla.) a sample of infected cells diluted 1:10. Results were 
expressed as follows: 
%  Infected cells =  No. plaques/plate ;< 5  )< dilution factor )<  100. 
No. cells/ml 
EM.--Cells infected with VSV for 24 h were washed, chilled to 0°C, and the pellet was re- 
suspended and fixed for l  h  at 0°C in a  solution of 0.5% formaldehyde-2% glutaraldehyde 
(Ladd Corp., Wilmette, Ill.) in Millonig's buffer, pH 7.3, made freshly each time. After fixing 
cells were washed three times in Millonig's buffer, immersed for  1 h  in cold 2% osmic acid 
(J. A. Samuel & Co., Inc., New York), washed twice in distilled water, and stained with 0.2% 
uranyl acetate (Fisher Scientific Co., Pittsburgh, Pa.) in water at room temperature overnight. 
The samples were then washed twice in distilled water and resuspended in 3-ml conical tubes in 
a  2% solution of agar in water, prewarmed to 50°C,  and centrifuged to form a  pellet. This 
procedure prevented any further loss of cells from samples. The tips of cooled,  solidified agar 
cones containing the infected cells were loosened by injection of water between the agar and 
tube wall through a  no.  18 needle, cut off, dehydrated, and embedded in Dureupan ACM- 
Fluka (ICN Corp., Chemical & Radioisotopes Div., Irvine, Calif.). 
The number and percent of infected cells were calculated from an enumeration of intact 
cells with virus, of all intact cells,  and of damaged cells.  An intact cell was considered to be 
infected with virus if one or more identifiable VSV particles was budding from the surface 
membrane or was located not more than 650 A  (diameter of VSV) from the surface. At least 
three sections of each block were counted and the mean of infected cells,  intact cells,  and 
damaged cells was determined. Cell types with virus are noted in Results. 
RESULTS 
Replication of VSV in Lymphoid  Cells from Hypersensitiz~e Guinea Pigs.- 
Lymph  node cells obtained from tuberculin-sensitive guinea pigs were cultured 
for 4  days  in medium  either with or without  specific  antigen,  PPD.  After in- 
fection  they were  plated  for  assay  of  infectious  centers  or fixed  for  EM.  The 
results  of  10  experiments  of  the VPA  are  presented  in Table  I  A.  There  is  a 
background  of  virus  plaque-forming  cells  of  approximately  1/1,000  cells 
(range 0.03-0.3 %)  in unstinmlated  cultures.  In cultures stimulated by antigen 
the number  of cells able to produce VSV by VPA  rose to  approximately  1.6 % 
(range 0.8-6.0%).  In these experiments ultrastructural  examination of control 
unstimulated  cultures  revealed  five  virus-producing  cells  among  395  intact 
and damaged  cells,  an incidence of  1.3 %  of those seen,  but none of these were 
lymphocytes.  In  PPD-stimulated  cultures  the  incidence  of  lymphocytes  with 
VSV was  1.9%  of total cells.  (See below for further comment  on these  results.) NOWAKOWSKI,  FELDI~AN,  KANO,  AND  BLOOM  1045 
TABLE I 
Incidence of VSV Replication in Primary Lymphoid Cells 
Cultured with  Total cells  Intact cells  Intact ceils  Intact  with virus  cells  Virus plaque-forming 
with virus  (% of total, EM)  ceils (% of total, VPA) 
A.  Tuberculin-Sensitive Guinea Pig Lymph Node Cells* 
Medium  395  273  5~  1.3  0.1  4- 0.02 
PPD  1282  553  28§  2.2  1.6  4- 0.4 
B.  Normal Mouse Spleen Cells[I 
Medium  ND¶  0.09  ±  0.01 
Con A  404  124  18  4.5  5.70  ±  0.06 
LPS  422  137  17"*  4.0  0.32  -4- 0.06 
* Cells were cultured 4 days with PPD. VSV was added at an MOI of 10 for an additional 
20-24 h. 
:~ Four of these five cells were macrophages;  one cell, without visible nucleus, was either a 
macrophage or a blast cell. 
§ 4 of these 28 cells were macrophages. 
I1 Cells were cultured for 48 h with Con A or LPS. VSV was added at an MOI of 10 for 
an additional 20-24 h. 
¶ ND, not determined. 
** Two of these cells were macrophages. 
Cells associated with virus were usually large lymphocytes which displayed 
some of the morphological features of transformed lymphocytes but were not 
typical mature blast cells (Figs.  1 and 2). Their cytoplasm, moderately abun- 
dant,  contained  numerous  ribosomes  and  some  polysomes,  a  few  profiles of 
rough  endoplasmic  reticulum,  inclusions,  and  several  mitochondria,  but  no 
lysosomes. Nuclei were large and showed a relative decrease of heterochromatin 
and  an  increase of  euchromatin.  Virions associated  with  infected  cells  were 
few in number and localized to a  short segment of cell membrane; occasionally 
only one was seen budding from the surface. Of the 28 cells seen to be produc- 
ing virus in the PPD-stimulated culture, 4  appeared to be macrophages  (Fig. 
3).  Of  the five cells with virus in control populations, four were macrophages 
and  one could not  be classified since the  section did not  include the nucleus. 
This cell was large and was either a  macrophage or a  blast cell. 
Replication of VS V  in Mouse Spleen Cells Cultured with Con A  or LPS.--In 
mouse spleen both T  and  B  lymphocytes are present and may be selectively 
stimulated to undergo blast transformation by Con A  (19)  and by LPS  (20). 
When mouse spleen cells were incubated with Con A for 48 h  and then exposed 
to VSV for an additional 24 h  in two experiments, approximately 4.5 %  of the 
total lymphocytes were seen in  the electron microscope to be associated with 
VSV.  In the VPA the percentage of VSV-producing lymphocytes found in  18 
experiments averaged 5.7 %  (range 3-10 %). When LPS was used to stimulate 
the  spleen  cultures  in  10  experiments,  the  incidence  of  infected  cells in  the 1046  PRODUCTION  OP  VESICULAR  STOMATITIS  VIRUS 
FIO. 1.  Lymphocyte from sensitized guinea pig lymph node incubated  for 3 days with 
PPD, and an additional day with VSV. Particles of VSV are clustered close to and budding 
from a narrow segment of the surfaces (inset). The nucleus is large and has peripheral hetero- 
chromatia  and some euchromatin. The cytoplasm contains a  small number of profiles of 
rough endoplasmic reticulum and numerous ribosomes. Arrows indicate areas shown in insets. 
X 20,000. Insets: Typical structure of VSV and budding are seen. X 47,000. 
VPA was 0.32%  (range 0.03-1.0%),  while in two experiments the figure was 
4% by EM. Mouse spleen cells cultured in medium without mitogens yielded 
an average of 0.09%  virus plaques in 14 experiments and were  consequently 
not scanned in the electron microscope. 
The cells associated with VSV were atypical lymphocytes (Figs. 4 and 5) that 
displayed the  morphology of  transformed lymphocytes; i.e.  they were  large, 
with  abundant cytoplasm and large irregularly shaped nuclei, and contained NOWAKOWSKI,  FELDMAN~ KANO,  AND  BLOOM  1047 
FIG. 2.  Lymphocyte from sensitized guinea pig lymph node incubated  for 3 days with 
PPD, and for an additional day with VSV. Particles of VSV are found adjacent to a segment 
of the surface and single particles (arrows) are seen on the opposite side. The cell is a large 
lymphocyte  with  an  indented  nucleus, abundant cytoplasm,  numerous  ribosomes, a  few 
simple profiles of rough endoplasmic reticulum, two swirls of smooth membranes, and several 
mitochondria. X 14,000. 
an  increased  amount of  rough  endoplasmic reticulum,  an  increase  of  mito- 
chondria,  several inclusions, and numerous ribosomes and polysomes. Spleen 
cells from LPS cultures could be distinguished from spleen cells of Con A  cul- 
tures  by an  extensive and  elaborate  rough  endoplasmic reticulum (compare 1048  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
FIG. 3.  Macrophage from sensitized  guinea pig lymph node releasing and  ingesting VSV. 
The  nucleus  appears  as  three  lobes.  Mitochondria  are  numerous.  Two  large granules  are 
present but ]ysosomes are not seen in this section.  X  17,000.  (3 a, 3 b)  Enlargements of seg- 
ments of the macrophage surface showing typical structure of VSV,  budding,  and ingestion. 
X 37,500. 
Figs.  4  and  5).  Not  all  transformed  cells  were  associated  with  virus.  Of  all 
LPS-treated cells found with surface virus, two were identified as macrophages. 
Replication  of  VS V in Conlinuous  Lymphoid Cell Lines.--Several  long-term 
lymphocyte culture lines were examined for their capacity to replicate VSV and 
the  data  are  shown  in  Table  II.  In  these  experiments,  lymphocytes  were  in- 
fected  with virus  either for  2  or 24  h.  Two murine  leukemia  lines, L1210  and NOWAKOWSKI,  FELDMAN~  KANO,  AND  BLOOM  1049 
Fro. 4.  Lymphocyte from  mouse spleen stimulated  with  Con A for 48 h. A number  of 
virus particles are scattered at periphery of cell (arrows). Cell shows features of a transformed 
lymphocyte: a large euchromatic nucleus, profiles of rough endoplasmic reticulum, many mito- 
chondria, numerous ribosomes. )< 12,500. 
C57B1/6, which do not carry the 0 surface marker for T  lymphocytes nor the 
complement  receptor  characteristic  of  B  lymphocytes  (10),  were  found  by 
VPA  to produce  low  levels  of VSV,  both  at  2  and  24  h.  Similarly,  the L2C 
guinea pig leukemia,  a  known  B  cell  leukemia  (10),  yielded  a  low percent  of 
virus plaque-forming cells. A  murine plasmacytoma, MOPC-104, that secretes 
large amounts of IgM immunoglobulin was active in producing VSV. In these 
cells typical cylindrical virions of VSV were seen budding from the surface and 
A-type particles were present in the cytoplasm (Fig. 6). 
In  contrast  to  the  results  observed  with  L1210  and  C57B1/6,  two  murine 1050  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
FIG. 5.  Lymphocyte from mouse spleen stimulated by LPS for 48 h and exposed to VSV 
for an additional  24 h. No virus is seen in this micrograph. The cell displays an extensive 
and dilated rough endoplasmic reticulum, greater and more complex than that usually visible 
in mouse splenic lymphocytes. Many lymphocytes with such characteristics were seen after 
exposure to LPS, a few of which had virus on their surfaces. X 18,000. 
lymphomas  containing lymphocytes  with  0  surface  antigens  (L5178Y  and 
EL-4)  showed  a  15-100-fold  higher  incidence of  virus-producing cells  when 
infected for 2 h. At 24 h  the percent of virus-producing cells decreased to 1-3 % 
of the 2 h  level in the LS178Y line and to 4  10% of the 2 h  level in the EL-4 
line. From examination of these lines in the electron microscope at 24 h  after 
infection, the number of intact cells was low and the percent of cells with virus 
was higher than that determined by VPA. NOWAKOWSKI, FELDMAN, KANO, AND  BLOOM  1051 
TABLE II 
Incidence of VSV Replication in Continuous Human and Murine Lymphoid Cell Lines* 
Cell line 
L1210 
C57B1/6 
L2C(Ig+) 
MOPC-104(Ig+) 
L5178Y(0+) 
EL4(0+) 
Wil-2 
8866 
Raji 
Origin 
Mouse 
Mouse 
Guinea pig 
Mouse 
Mouse 
Mouse 
Human 
Human 
Human 
Total 
cells 
ND~ 
ND 
ND 
39 
60 
34 
193 
180 
178 
Intact 
cells 
16 
14 
3 
137 
124 
137 
Intacl 
cells wi 
virus 
12 
5 
1 or 
130 
44 
19 
Intact cells 
with virus 
(% of total, 
EM) 
31 
8 
3or6 
67§ 
24 
11 
Virus plaque-forming 
cells (% of total, VPA) 
2h  24h 
infection  infection 
0.4-0.9  1.6-4.0 
2.1-2.5  2.3 
1.3  1.1-1.9 
24  5.7 
37-42  0.4-1.3 
39-50  1.7-4.8 
8-15  70-80 
1.5-2.7  5.5-14 
0.7-2.2  15-20 
* For EM, cells were examined at 24 h after incubation with VSV at MOI of 10. 
ND, not examined  by EM since the proportion of infectious  centers in the  VPA was 
very low. 
§ In other studies with Wil-2 the percent of cells replicating virus ranged from 85 to 100%. 
Three  human  lymphoblastoid  lines  supported  replication  of  VSV  but  at 
different levels of efficiency (Table II). Wil-2 showed a high percent of infected 
cells, particularly at 24 h, reaching 80 %  by VPA and almost 70 %  by electron 
microscopic examination  (Fig.  7).  In  the  Raji  and  8866  lines  (the  latter se- 
cretes IgG), virus plaque-forming cells at 24 h  ranged from 5  to 20% by VPA 
and from  11  to 24%  by morphologic examination (Fig. 8).  In these lines, the 
percent  of virus-producing cells was  markedly lower  at  2  h  than  at  24  h,  a 
result  that  differed  from  that  observed  in  some  of  the  mouse  lines.  Virus 
particles on  Raji and  8866  cells were less numerous  than  the numbers  found 
associated with  Wil-2,  and  often  appeared  over  a  few  segments  of  the  cell 
surface  in  clusters  (Fig.  8).  In  all of the  cell lines studied,  both  human  and 
mouse,  the number  of virus particles per producer cell was greater  than  that 
seen in lymphoid cells from donor animals that were exposed to specific antigen, 
Con A  or LPS. 
DISCUSSION 
The intent of this work was  to  examine morphologically the kinds of lym- 
phoid  cells, both  in primary and  in  long-term cultured populations, that  are 
capable of  replicating VSV.  VSV  was  chosen  since  it  had  been  shown  that 
human  lymphocytes, stimulated by phytohemagglutinin  (PHA)  and  infected 
simultaneously, produced maximum yields of VSV in 24 h  (14) ; i.e., the ability 
to produce VSV  reflects a  relatively early step in  the  activation of lympho- 
cytes.  Secondly,  the  virus  has  a  distinctive morphological  appearance  (21). 
Thirdly, it was the virus best studied in the VPA. 1052  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
FIG. 6.  Portion of a  murine plasma cell tumor  (MOPC-104)  showing several particles of 
VSV budding from cell surface and  A-type palticles in  cytoplasm.  Suspension of myeloma 
cells was incubated with VSV,  MOI  =  10, for 24 h.  X  14,000. 
Replication of VSV,  an  enveloped RNA  virus of the rhabdovirus  group,  is a 
complex process  and  consists  of several stages,  some of which  are not entirely 
understood  (22).  Virus must  first be adsorbed  to  the host cells, penetrate,  and 
be uncoated.  Then the genome must be transcribed  to provide messenger RNA 
FIG. 7.  Several Wil-2 human lymphoblastoid cells showing the replication of VSV in large 
numbers  around  the periphery of the cells. 80-100%  of cells in continuous culture were in- 
fected after exposure to MOI  =  10 for 24 h.  X  7,700.  (7 a)  Enlargement of portion of Fig. 7 
to show viral detail and budding.  X 34,500. 1053 1054  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
Fio. 8.  8866 human lymphoblastoid cell with VSV dispersed  over a large part of the cell 
surface and several clusters  of VSV enclosed in cytoplasmic vacuoles or section through cell 
projection. X 14,000. Inset: Enlargement of zone at arrow to show alteration and disintegra- 
tion of VSV. X 40,000. 
(mRNA)  for  viral protein  synthesis,  and  then  replicated.  Finally the  virus 
must be assembled before mature particles start budding at the host cell sur- 
face considerably. The host cell is ultimately lysed, but VSV buds at the mem- 
brane  before lysis occurs. It is known  that  there is a  rapid inhibition of host 
cell macromolecular synthesis after infection of cells that are highly susceptible 
to  VSV  (23-25).  There  is no  information  concerning  the  interaction  of VSV 
with  cells  that  do  not  replicate  this  virus  efficiently. Activation  of  cells to 
produce VSV  cannot  at present be explained by what  is known  of the intra- NOWAKOWSKI,  FELDMAN~ KANO,  AND  BLOOM  1055 
cellular  events  that  occur  in  antigen  or  mitogen-stimulated  cells.  Nor  is  it 
feasible at this time to relate activation to one or more events associated with 
the different stages of the mitotic cycle. Nonetheless, replication of VSV seems 
to be an excellent means of enumerating a small number of sensitized lympho- 
cytes that respond to antigen. 
Among guinea pig lymph node cells from sensitized donors,  1.5-2.0% were 
capable of replicating VSV in vitro in  the presence of antigen.  Lymph node 
cells  from  the  same pools  cultured  in  the  absence  of  antigen  yielded  a  low 
background of infectious centers and a  somewhat higher background level by 
morphologic examination.  In  the  electron  microscope four  of five cells with 
VSV were macrophages and the fifth was not a  lymphocyte. Among antigen- 
stimulated cells,  4  of 28 cells with VSV were macrophages and the remainder 
were large lymphocytes. Neither small lymphocytes nor blast cells were found 
to replicate the virus. These observations indicate that (a) the cells responsive 
to antigen,  as detected  by a  marker virus, were lymphocytes; (b)  cells other 
than  lymphocytes were  capable  of  replicating  VSV  even  without  antigenic 
stimulation;  and  (c)the  correlation  of  results  obtained  by  VPA  and  mor- 
phologic examination was very close. 
When  mouse spleen cells were stimulated  by mitogens that act selectively 
on the T  lymphocytes (Con A) or B  lymphocytes (LPS), an increase in virus- 
producing cells was found. In the case of Con A this was of the order of 5.7 % 
and in  the  case of LPS,  0.3 %  of the  cells. The agreement between the VPA 
and  EM  counts was very good with  Con A  and less so with LPS.  The cells 
producing VSV in the Con A-stimulated cultures, presumably T  lymphocytes, 
showed the features of transformed lymphocytes, reminiscent of PHA-stimu- 
lated  human  lymphocytes  (5).  Cells  with  VSV  in  LPS-stimulated  cultures, 
presumably B lymphocytes, showed an extensive rough endoplasmic reticulum 
resembling  lymphocytes  transformed  by  pokeweed  mitogen  (26,  27),  and 
these  were  readily  distinguished  from lymphocytes transformed  by  Con  A. 
In an attempt to determine if there was a  predilection of T  or B  lympho- 
cytes  for  virus  replication,  several  murine  tumor  lines  were  studied.  Two 
murine  lymphomas bearing  the  8 marker of T  lymphocytes were  capable of 
VSV replication. So was the MOPC-104, a plasma cell tumor line presumed to 
be derived from B  lymphocytes. This finding raises the questions of whether 
VSV is produced equally well by activated B  and T  lymphocytes or whether 
tumor cells have an intrinsic quality, associated with neoplasia, that facilitates 
VSV  replication.  For  example,  granulocytes  and  mast  cells  are  unable  to 
produce virus (28),  yet the mast cell  tumor P  815  replicates VSV at approxi- 
mately 80 % efficiency3 
Determination  of  the  percent  of virus-producing  cells  in  murine cell lines 
by VPA  and  EM  examination  yielded  somewhat  differing  results.  At  24  h 
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after VSV infection,  the percent of  cells  with  virus  was  higher  by EM  enu- 
meration  than  the percent calculated by VPA.  This may be explained on the 
basis  that  the  lyric  cycle in  these  cells was  considerably  shorter  than  24  h. 
When infected cells were plated on monolayers 24 h after infection, many may 
have  already been killed  and  could  no  longer  form infectious  centers  during 
the ensuing 48 h. In addition,  the numbers of intact and damaged cells of the 
murine lines remaining at 24 h after infection with VSV were small and did not 
provide a suitable basis for accurate calculation. 
By contrast,  the human lymphoblastoid lines showed at 24 h  an increase of 
virus-containing  cells over the  2  h  levels. This ma~  have been due  to infec- 
tion  of new cells by VSV released from a  small number,  and  to an enduring 
viability, at least for some hours,  despite VSV  infection.  The ability to pro- 
duce  VSV  among  the  human  lymphoblastoid lines  varied  considerably.  The 
basis for these differences is not clear. For example, in Raji, a  nonsecretor of 
immunoglobulin  (29)  and  in  8866,  a  secretor  of  immunoglobulin,  virus  pro- 
duction was poor, while in Wil-2, which only produces surface IgG, efficiency 
of VSV production was ahnost as great as in HeLa cells.  Interestingly, at the 
beginning of this  study the 8866  line produced VSV  at  an efficiency of only 
3 %, and 9 mo later its ability to replicate the virus had risen spontaneously to 
30%.  The  possibility  that  Raji  and  8866  cell  lines  produce  interferon  was 
examined by preincubating secondary human skin fibroblasts in supernatants 
from growing lymphoblastoid cells and challenging  the monolayer with VSV. 
No protecting  activity was found  in  the  supernatants  at  dilutions  of  1:8  or 
greater. 
Technical  Considerations:  Comparison  between EM  and  VPA.--For  quanti- 
tative measurement by either assay, it must be possible to distinguish  virus- 
producing cells from the remaining number of cells.  It is difficult to obtain an 
accurate  count of total  cells after several days in  culture,  since  the viability 
of the cultured cells varies drastically with cell source, type of stimulation, and 
duration of culture. Fewer cells survive 3-5 days in nonstimulated cultures of 
primary lymphoid  cells  than  in  cultures  stimulated  by antigen  or  mitogen. 
With  VPA,  one  selects  essentially  for  viable  cells  because  during  the  pro- 
cedures  of  infection,  neutralization,  eight  centrifugations,  etc.,  nonviable 
cells largely disintegrate.  On  the  other hand,  an  unknown  number of viable 
cells  may be  damaged  in  the  handling.  With  respect  to  processing  for  EM 
study,  there  are  losses  of  cells  during  fixation  and  dehydration,  which  are 
partially overcome by the  agar-embedding technique.  In  the  electron  micro- 
scope  the  percentage of damaged  cells  that  could  be visualized  ranged from 
25  to 90%.  The great advantage of the VPA is the ability to sample 104-106 
cells on a  single plate for virus plaque-forming cells.  However, it is clear that 
cells other  than lymphocytes can  replicate VSV,  and  the  great virtue of the 
electron microscope is that it enables one  to distinguish  cell  types, and often 
stages of development within  the  lymphoid  cell  series.  The major drawback NOWAKOWSKI~ FELDMAN~ KANO,  AND  BLOOM  1057 
is that of screening enough sections and cells to detect low percentages of cells 
replicating viruses. In those instances in which sufficient numbers of cells were 
observed,  the  correlation between  the EM  analysis  and  VPA was  excellent. 
SUMMARY 
A  variety of lymphoid  cell  populations  were  examined  in  terms  of  their 
ability to replicate vesicular stomatitis virus (VSV),  a lyric, RNA-containing 
virus maturing at the cell surface. The number of cells capable of producing 
VSV was  estimated in  terms of infectious centers by the virus plaque assay 
(VPA),  and  morphologically by  electron  microscopy  (EM).  The  lymphoid 
cells examined in this study included: (a) lymph node cells from delayed hy- 
persensitive guinea pigs stimulated by specific antigen,  (b) mouse spleen cells 
activated by selective bone marrow-derived (B) cell  and thymus derived (T) 
cell  mitogens, and  (c) cells of human  and murine continuous lymphoblastoid 
or lymphoma lines. 
In  unstimulated  cultures of guinea  pig lymph node  cells there  is  a  back- 
ground  of  approximately  1  in  1,000  cells which  produces VSV;  in  purified 
protein  derivative  (PPD)-stimulated  cultures  the number of cells producing 
virus was 1.6 % in the VPA and 1.9 % by EM. These cells were large lympho- 
cytes with some morphological features of transformed lymphocytes but were 
not typical blast cells.  A few macrophages were associated with virus in both 
stimulated  and  control  cultures.  These  observations  indicate  that  (a)cells 
responsive  to  antigens,  as  detected  by  a  marker  virus,  were  lymphocytes; 
(b)  cells other  than  lymphocytes (macrophages)  were  capable  of replicating 
VSV  even  without  antigenic  stimulation;  and  (c) the  correlation  of  results 
obtained b3 VPA and morphologic examination was usually quite good. 
Of  the  total  number  of mouse  spleen  cells  stimulated  with  concanavalin 
(Con A), a T  cell mitogen, 4.5 (EM)  5.7%  (VPA) were associated with VSV. 
These were  characteristic  transformed lymphoeytes, similar  to phytohemag- 
glutinin  (PHA)-stimulated human  lymphocytes. In  contrast Escherichia  coli 
lipopolysaccharide  (LPS)-treated  mouse  spleen  cultures  contained  lower 
numbers of virus plaque-forming cells.  The majority of such  cells associated 
with virus displayed extensive rough endoplasmic reticulum. 
Two cultured routine lymphomas containing lymphocytes with  the  0  sur- 
face  marker  (L5178Y  and  EL-4)  showed  a  15-100-fold  higher  incidence  of 
virus-producing  cells  than  leukemias  (L1210  and  C57B1/6)  which  did  not 
carry this  marker.  Similarly,  the L2C  guinea pig leukemia,  a  known  B  cell 
leukemia, yielded a  low percent of virus plaque-forming cells  (<2%).  How- 
ever,  MOPC-104,  a  plasma  cell  tumor presumed  to be of B  cell  origin, was 
found  to  be  an  efficient virus  producer.  There was  a  wide  variation  in  the 
efficiency of VSV  replication  among  human  lymphoblastoid lines.  One  line, 
Wil-2, produced 80% infectious centers after 24 h of exposure to VSV, and all 
cells were associated with virus at the EM level. The relationship between the 1058  PRODUCTION  OF  VESICULAR  STOMATITIS  VIRUS 
virus-producing cells and  different lymphocyte subpopulations  as well  as the 
efficiency  of  the  two  assays  for  studying  virus-producing  lymphocytes  is 
discussed. 
The authors would like to express their great indebtedness to Dr. Gabriel Godman for his 
many helpful  technical suggestions  and  valuable criticism and  advice.  We  are especially 
grateful to Dr. R. Lerner for providing us with the human  lymphoblastoid cell  lines,  Dr. 
L, Manson for the LS178Y murine lymphoma, Dr. I. Green for the L2C guinea pig leukemia, 
and Dr. J. Buxbaum for the MOPC-104 cells. We also wish to thank Mrs. Helen Hays and 
Mrs. Karen Prescott for their help in electron microscopy and photography. 
REFERENCES 
1.  Ling,  N.  R.  1968. Lymphocyte  Stimulation.  North-Holland  Publishing  Co., 
Amsterdam. 
2.  Naspitz, C. K., and M.  Richter.  1968.  The action of phytohemagglutination in 
vivo and in vitro,  a review. Prig. Allergy. 12:1. 
3.  Inman, D. R., and R. H. Cooper. 1963. Electron microscopy of human lympho- 
cytes after  incubation with  a  phytohemagglutinin. J.  Cell  Biol.  19:441. 
4.  Tanaka, Y., L. B. Epstein, G. Brecker, and F. Stohlman. 1963. Transformation of 
lymphocytes in cultures of human peripheral blood. Blood  J. Hematol. 22:614. 
5.  Douglas, S. D.  1971. Human lymphocyte growth in vitro: morphologic, biochem- 
ical and immunologic significance. Int.  Rev. Exp.  Pathol.  10:41. 
6.  Lawrence, H. S., and M. Landy, editors. 1969. Mediators of Cellular Immunity. 
Academic Press, Inc., New York. 
7.  Perlmann,  P.,  and  G.  Hohn.  1969. Cytotoxic effects of lymphoid cells in vitro. 
Adv. Immunol. 11:117. 
8.  Bosman, C., and J. D.  Feldman. 1970. Cellular events during the expression of 
immunologic memory. Clin. Exp. Immunol. 7:565. 
9.  Gudat, F. G., T. N. Harris, S. Harris, and K. Hummeler.  1971. Studies on anti- 
body-producing  cells.  III.  Identification  of  young  plaque-forming  cells  by 
thymidine-~H labeling. J. Exp. Med. 134:1155. 
10.  Shevach, E. M., J. D. Stobo, and I. Green. 1972. Immunoglobulin and 0-bearing 
murine leukemias and lymphomas. J. Immunol. 108:1146. 
11.  Wilson, D.  B.,  and  R.  E.  Billingham.  1968. Lymphocytes and  transplantation 
immunity. Adv. Immunol. "/:189. 
12.  Mackaness,  G. B.  1969. The influence of immunologically committed lymphoid 
cells on macrophage activity in vivo. J. Exp. Med. 129:973. 
13.  Bloom, B. R., L. Jimenez, and P. I. Marcus. 1970. A plaque assay for enumerating 
antigen-sensitive cells in delayed type hypersensitivity. J. Exp.  Med.  139.:16. 
14.  Edelman, R., and E. F. Wheelock. 1966. Vesicular stomatitis virus replication in 
human  leukocyte  cultures:  enhancement  of  phytohemagglutinin.  Science 
(Wash. D.C.). 154:1053. 
15.  Miller,  G.,  and  J.  F.  Enders.  1968. Vaccinia virus  replication and  cytopathic 
effect  in  cultures  of  phytohemagglutinin-treated  human  peripheral  blood 
leukocytes. J.  ViroI.  9.:787. 
16.  Jimenez, L., B. R. Bloom, M. R. Blume, and H. F. Oettgen. 1971. On the number 
and  nature  of  antigen-sensitive lymphocytes in  the  blood of  delayed hyper- 
sensitive donors. J. Exp. Med. 133:740. NOWAKOWSKI~  :FELDMAN~ KANO,  AND  BLOOM  1059 
17.  Agrawal, B. B. L., and I. J. Goldstein. 1965.  Specific binding of concanavalin A 
to cross-linked dextran gels. Biochem. J. 96:23c. 
18.  Jimenez, L.,  and  B.  R.  Bloom.  1971. In:  In  Vitro  Methods  of  Cell-Mediated 
Immunity.  Method  37.  B.  R.  Bloom  and  P.  R.  Glade,  editors.  Academic 
Press, Inc., New York, 553. 
19.  Stobo, J. D., H.  S. Rosenthal, and W. E. Paul.  1972.  Functional heterogeneity 
of murine  lymphoid cells. I.  Responsiveness  to  and  surface  binding  of con- 
canavalin A and phytohemagglutinin. J. Immunol. 108:1. 
20.  Gery, I., J.  Kruger, and  S. Z.  Spiesel. 1972.  Stimulation of B-lymphocytes by 
endotoxin. J. Immunol. 108:1088. 
21.  Nakai, T., and A. F. Howatson.  1968. The fine structure ot vesmular stomatids 
virus. Virology. 35:268. 
22.  Howatson, A. F.  1970. Vesicular stomatitis and related viruses. Adv.  Virus Res. 
16:195. 
23.  Wagner, R. R., and A. S. Huang.  1966. Inhibition of RNA and interferon syn- 
thesis in Krebs-2 cells infected with vesicular stomatitis virus.  Virology. 28:1. 
24.  Yaoi,  hr.,  H.  Mitsui,  and  M.  Amano.  1970.  Effect of  UV-irradiated vesicular 
stomatitis virus on nucleic acid synthesis in chick embryo cells. J. Gen.  Virol. 
8:165. 
25.  Wagner,  R.  R.,  R.  M.  Snyder,  and  S.  Yamazaki.  1970.  Proteins  of  vesicular 
stomatitis virus: kinetics and cellular sites of synthesis. J.  Virol.  5:548. 
26.  Chessin, L. N., J. BSrjeson, P. D. Welsh, D. S. Stevens, and H. L. Cooper. 1966. 
Studies on  human  peripheral blood lymphocytes in  vitro. II.  Morphological 
and biochemical studies on the  transformation of lymphocytes by pokeweed 
mitogen. J. Exp. Med. 124:873. 
27.  Douglas, S. D., P. F. Hoffman, J. BSrjeson, and L. N. Chessin. 1967. Studies on 
human peripheral blood lymphocytes in vitro. III. Fine structural features of 
lymphocyte formation by pokeweed mitogen.  J.  Immunol. 98:17. 
28.  Wheelock, E. F., and R. Edelman.  1969.  Specific role of each human leukocyte 
type in viral infections. J. Immunol. 103:429. 
29.  Lerner, R. A., P. J.  McConahey, and F. J. Dixon.  1971. Quantitative aspects of 
plasma-membrane  associated  immunoglobulin  in  clones  of  diploid  human 
lymphocytes. Science (Wash. D.C.). 173:60. 